Global Pulse

分类： health

  • Abu Dhabi’s health festival helps residents of all ages beat lifestyle challenges

    Abu Dhabi’s health festival helps residents of all ages beat lifestyle challenges

    Abu Dhabi has launched an innovative public health initiative that is redefining how communities engage with wellness. The Festival of Health (FOH), organized by the Abu Dhabi Public Health Centre (ADPHC), is bringing comprehensive health programming directly to residents across the emirate’s three regions through December.

    The festival represents a strategic shift from conventional health education to experiential learning. Rather than simply disseminating information, FOH creates immersive environments where participants actively engage with wellness practices. The programming addresses four critical lifestyle challenges identified by health authorities: physical inactivity, poor nutritional habits, inadequate sleep quality, and escalating stress levels.

    Dr. Omniyat Al Hajeri, Executive Director of Community Health at ADPHC, emphasizes the festival’s community-centered approach: “This initiative creates spaces where individuals and families can experience health through movement, food, rest, and connection in ways that feel natural and enjoyable. We’re demonstrating how healthier habits can integrate seamlessly into daily routines.”

    The festival’s rollout spans multiple locations and dates: Al Hudayriyat Island (December 12-16), Madinat Zayed Public Park in Al Dhafra (December 19-21), and Al Jahili Park in Al Ain (December 26-28). With over 140 diverse activities designed for all age groups, the event aims to attract approximately 30,000 participants.

    Early attendees like Nova Lijoy report unexpectedly extended engagements with the festival’s offerings. “I accompanied friends initially but remained for over five hours because the experience was genuinely enjoyable,” Lijoy noted. “The activities successfully make fitness accessible and fun for both children and adults.”

    The festival’s methodology focuses on creating social reinforcement for healthy behaviors. Dr. Al Hajeri explains: “When people move, cook, relax, and learn together, health becomes social and relatable. These shared experiences build confidence and reduce barriers to maintaining positive habits beyond the event itself.”

    Rather than measuring success solely through attendance metrics, ADPHC is tracking qualitative engagement and sustained behavioral changes. The festival serves as an entry point to broader community health initiatives, connecting participants with long-term wellness resources and support systems.

  • Six mobility exercises can improve your running performance

    Six mobility exercises can improve your running performance

    Health specialists are advocating for a targeted mobility regimen to complement running routines, emphasizing its role in injury prevention and performance enhancement. According to Vikash Sharma, owner of Perfect Stride Physical Therapy in New York, while strength training remains fundamental for runners, strategic mobility work addresses critical biomechanical efficiencies often overlooked.

    Colleen Brough, Assistant Professor of Physical Therapy at Columbia University and founding director of Columbia RunLab, observes that restricted mobility frequently leads runners to develop compensatory movement patterns, increasing injury risk. Stiffness in key areas like the big toe or thoracic spine can force undue stress on ankles, knees, or the lower back during a runner’s stride.

    Dr. Sharma has designed a concise 20-minute routine focusing on joints most vital for runners: the big toe, hip, ankle, thoracic spine, and midfoot. The protocol requires minimal equipment—an exercise mat, a step or box, and a chair. Experts recommend integrating these exercises multiple times daily initially, even during brief breaks, to effectively build mobility before transitioning to a pre-run maintenance routine.

    The exercises include:
    1. Quadruped Rock Backs: Enhances big toe mobility through controlled rocking motions.
    2. Deficit Heel Raises: Boosts ankle mobility and calf strength using an elevated surface.
    3. Mini Split-Stance Pronation Rocks: Promotes midfoot mobility via weighted rocking and rotation.
    4. Hip Flexor Stretch with Pelvic Tilts: Increases hip extension capacity through kneeling stretches and pelvic movements.
    5. Kickstand Hip Hinge with Opposite Hand Reach: Strengthens glutes and improves hip and thoracic rotation using a single-leg hinge motion.
    6. Side-Lying Open Book Rotations: Improves thoracic spine mobility through controlled upper-body rotations while lying on one side.

    This approach, originally featured in The New York Times, underscores that consistent mobility practice not only supports a more efficient running stride but also significantly mitigates the risk of chronic pain and injury.

  • UAE approves gene therapy for new age group in spinal muscular atrophy patients

    UAE approves gene therapy for new age group in spinal muscular atrophy patients

    In a landmark decision for medical advancement, the United Arab Emirates has significantly broadened access to a groundbreaking gene therapy for spinal muscular atrophy (SMA). The Emirates Drug Establishment (EDE) has granted regulatory approval for Itvisma (onasemnogene abeparvovec) to now include eligible adults and children aged two years and above.

    This authorization elevates the UAE to the position of the second nation worldwide to approve this innovative treatment, solidifying its status as a regional pioneer in facilitating patient access to cutting-edge medical solutions. The therapy utilizes an adeno-associated viral vector to directly address the genetic root cause of SMA by delivering a functional replacement for the defective SMN1 gene.

    Dr. Fatima Al Kaabi, Director-General of the EDE, emphasized the decision’s significance, stating it underscores the UAE’s dedication to integrating advanced genetic therapies into its healthcare framework, particularly for rare genetic disorders. The approval followed rigorous evaluation of clinical evidence demonstrating sustained improvements in patients’ motor functions and a consistently positive safety profile throughout all trial phases.

    The regulatory move is a strategic component of the UAE’s vision to cultivate a world-class, innovative, and sustainable healthcare ecosystem. Dr. Al Kaabi highlighted the efficiency of the national health system in evaluating and approving novel pharmaceuticals according to the highest international scientific standards, while maintaining a careful balance between speed, scientific rigor, and transparency.

    Mohamed Ezz Eldin, Head of the GCC Cluster at Novartis—the therapy’s developer—hailed the approval as a pivotal achievement for patients and their families. He noted that close collaboration with the EDE aims to ensure rapid and equitable access to this one-time interventional treatment, potentially altering the disease’s trajectory for many.

    This milestone also reflects Novartis’s expanding commitment to neurology, building on its expertise in SMA and multiple sclerosis to address neuroimmunology, neurodegenerative, and neuromuscular diseases. For the UAE, it strategically reinforces its ambition to become a regional hub for pharmaceutical innovation, delivering high-value therapies that meet stringent quality and safety benchmarks.

  • Syria monitor says at least five IS members killed in US’ retaliatory strikes

    Syria monitor says at least five IS members killed in US’ retaliatory strikes

    In a landmark development for ophthalmic medicine in the Middle East, the prestigious Bascom Palmer Eye Institute has entered into a strategic partnership with the Emirates Society of Ophthalmology. The agreement, formalized in Abu Dhabi, establishes a collaborative framework aimed at elevating eye care standards, advancing clinical research, and enhancing medical education throughout the region.

    The partnership brings together one of the world’s top-ranked ophthalmology institutions with the UAE’s leading professional organization for eye care specialists. This alliance will facilitate knowledge exchange programs, joint research initiatives on region-specific eye diseases, and the development of specialized training programs for ophthalmologists and medical staff.

    Key components of the agreement include establishing fellowship exchange programs, creating standardized treatment protocols for prevalent regional conditions such as diabetic retinopathy and glaucoma, and organizing annual ophthalmology conferences that will attract international experts to Abu Dhabi. The collaboration also aims to implement advanced telemedicine capabilities to extend specialist care to underserved areas.

    This initiative aligns with Abu Dhabi’s broader healthcare strategy to position itself as a medical hub for specialized care. By leveraging Bascom Palmer’s expertise in complex eye conditions and research capabilities, combined with the Emirates Society’s regional insights and network, the partnership seeks to significantly reduce preventable blindness and visual impairment across the UAE and neighboring countries.

    The timing of this collaboration is particularly significant given the increasing prevalence of diabetes-related eye diseases in the Gulf region and the growing demand for specialized ophthalmology services. Both organizations have committed to measuring the partnership’s impact through improved patient outcomes, increased research publications, and enhanced professional training metrics over the coming years.

  • Sudan PM heads to New York for UN talks: govt sources

    Sudan PM heads to New York for UN talks: govt sources

    In a landmark development for ophthalmic medicine, the prestigious Bascom Palmer Eye Institute and the Emirates Society of Ophthalmology have officially cemented a strategic partnership. This collaborative endeavor, formalized through a comprehensive agreement, is poised to significantly elevate the standard of eye care services and ophthalmic research within the United Arab Emirates and the broader Gulf region.

    The alliance brings together the formidable research capabilities and clinical expertise of Bascom Palmer—consistently ranked among the top ophthalmology centers in the United States—with the regional leadership and deep community insights of the Emirates Society of Ophthalmology. The partnership is strategically designed to be multifaceted, encompassing several critical initiatives.

    A primary focus will be on enhancing medical education through the establishment of specialized training programs, fellowship opportunities, and continuing medical education (CME) courses for local ophthalmologists, optometrists, and allied health professionals. Furthermore, the collaboration will champion innovative research projects aimed at addressing region-specific eye health challenges, including genetic disorders and diseases prevalent in the Middle East.

    The agreement also paves the way for knowledge exchange, facilitating the transfer of cutting-edge surgical techniques, technological advancements, and best practices in patient care. This initiative is expected to directly benefit patients by expanding access to world-class diagnostic and treatment protocols, ultimately improving clinical outcomes and fostering a new era of ophthalmic excellence in the UAE.

  • US awards no-bid contract to Denmark scientists studying hepatitis B vaccine in African babies

    US awards no-bid contract to Denmark scientists studying hepatitis B vaccine in African babies

    A controversial $1.6 million contract awarded by the Trump administration to Danish researchers is generating intense ethical debates within the global public health community. The no-bid agreement funds a five-year study examining hepatitis B vaccination effects on 14,000 newborns in Guinea-Bissau, where the disease remains prevalent.

    The research team from the University of Southern Denmark, led by Christine Stabell Benn, will conduct a randomized controlled trial withholding standard hepatitis B vaccines from certain infants at birth. Participants will be monitored for mortality rates, illness patterns, and developmental outcomes, with initial cohorts tracked for five years to assess potential neurological and behavioral impacts.

    Medical experts worldwide have expressed grave concerns about the study’s ethical framework. Dr. Boghuma K. Titanji, an infectious disease specialist at Emory University, condemned the research as ‘unconscionable,’ noting that established medical consensus confirms the vaccine’s effectiveness in preventing liver disease and premature death in newborns. The study’s design—withholding proven protection from Black infants in an impoverished nation—has drawn comparisons to the infamous Tuskegee syphilis study.

    The award process bypassed standard CDC protocols, with Department of Health and Human Services officials reportedly instructing agency staff to approve the unsolicited proposal using special funding. Internal communications reveal CDC scientists expressing outrage over the arrangement, which skipped customary ethical reviews within the agency.

    The research team maintains their study represents a unique scientific opportunity, as Guinea-Bissau currently doesn’t recommend birth-dose hepatitis B vaccination but plans to implement universal newborn immunization by 2027. However, critics note the researchers’ history of controversial findings and association with vaccine-skeptic circles, including praise from U.S. Health Secretary Robert F. Kennedy Jr., who has previously questioned vaccine safety.

    Public health experts warn the study could exacerbate vaccine hesitancy in Africa and beyond while exposing vulnerable infants to preventable disease risks without scientific justification.

  • National health body asks consumers to read nutritional information on food labels

    National health body asks consumers to read nutritional information on food labels

    In a significant move to bolster public health awareness, China’s National Health Commission (NHC) has issued a nationwide appeal for consumers to actively scrutinize nutritional information on food packaging. The initiative accompanies the upcoming implementation of revised labeling standards for prepackaged foods, with a strong emphasis on digital innovation to enhance accessibility.

    NHC spokesman Yang Jinrui announced that updated ‘General Rules for Nutrition Labeling of Prepackaged Foods’ are scheduled to take full effect on March 16, 2027. However, food manufacturers are being actively encouraged to adopt these enhanced standards ahead of the mandatory deadline. The revised regulations introduce a critical update by classifying saturated fats and sugars as mandatory core components that must be prominently displayed alongside existing requirements for total fat and sodium.

    A groundbreaking aspect of the new framework involves the integration of digital labeling technology. Food enterprises will be incentivized to incorporate QR codes on packaging, which consumers can scan to access comprehensive product information through digital interfaces. These smart labels will feature adjustable font sizes, voice recognition capabilities, and video playback functions—innovations specifically designed to assist elderly consumers and those with visual impairments.

    Furthermore, the updated labeling standards will provide clearer contextual information by indicating what percentage of the recommended daily intake a single serving of the product contributes for each nutrient. Health authorities emphasize that developing the habit of reading nutritional information represents a fundamental step toward making informed dietary choices and safeguarding long-term family health, particularly as China addresses nutrition-related public health challenges.

    The commission’s announcement reflects China’s broader commitment to utilizing technological solutions and regulatory measures to promote preventive healthcare and consumer empowerment in nutritional decision-making.

  • Bascom Palmer Eye Institute Abu Dhabi, Emirates Society of Ophthalmology sign strategic partnership agreement

    Bascom Palmer Eye Institute Abu Dhabi, Emirates Society of Ophthalmology sign strategic partnership agreement

    Abu Dhabi witnessed a significant healthcare collaboration as Bascom Palmer Eye Institute Abu Dhabi and the Emirates Society of Ophthalmology (ESO) formalized a strategic partnership through a Memorandum of Understanding. The ceremony, held at Bascom Palmer’s Abu Dhabi facility, established a framework for cooperative efforts to enhance ophthalmic education, research, and clinical standards throughout the United Arab Emirates.

    This alliance brings together ESO, the UAE’s premier professional organization representing ophthalmologists, and the Abu Dhabi branch of the internationally acclaimed Bascom Palmer Eye Institute, which has maintained its position as the top-ranked ophthalmology center in the United States for 24 consecutive years according to U.S. News & World Report.

    Dr. Sheikha Noura Al Qassimi, President of ESO, characterized the agreement as a transformative milestone for ophthalmic advancement in the region. ‘This partnership embodies our mutual dedication with Bascom Palmer to propel ophthalmic education, clinical excellence, and innovation across the UAE,’ she stated. ‘We are establishing a comprehensive platform for scientific programming, professional training, and knowledge exchange that will strengthen clinical standards and contribute to sustainable eye care development throughout the Emirates.’

    The collaboration extends beyond conventional conference partnerships to include initiatives focused on best practice implementation, public awareness campaigns, and unique opportunities for Emirati medical students and residents to engage with Bascom Palmer’s global faculty and advanced facilities.

    Dr. Zain Kenderian, CEO of Bascom Palmer Eye Institute Abu Dhabi, emphasized the partnership’s broader implications: ‘This represents a pivotal moment for ophthalmic education and professional development in the UAE. Our joint commitment with ESO will elevate training, research, and clinical excellence for the benefit of medical professionals and the community at large. This memorandum initiates a long-term journey to advance regional eye care.’

    A joint oversight committee will ensure the partnership delivers tangible outcomes. Suhail Jaffar Al Zarouni, Board Chairman of Bascom Palmer Abu Dhabi, highlighted the practical benefits: ‘Collaborating with ESO enables us to directly bring Miami’s pioneering faculty and research to UAE professionals, creating lasting impact through shared knowledge and best practices.’

    The ceremony concluded with both institutions expressing confidence that their collaboration will accelerate progress in addressing regional eye health challenges, including diabetic retinopathy and pediatric care, while reinforcing the UAE’s emerging status as a hub for medical excellence.

  • Age limit for blood donors may be raised

    Age limit for blood donors may be raised

    China is poised to significantly revise its blood donation policies by potentially raising the maximum donor age from 55 to 65 years and reducing the minimum donation interval from six months to just 90 days. The National Health Commission announced these proposed changes on Wednesday as part of a draft amendment to the country’s Blood Donation Law, which has remained unchanged since its inception in 1997.

    The initiative aims to align China’s blood donation standards with international practices and contemporary medical research. According to the commission, these adjustments would help address the nation’s persistent blood shortages while maintaining strict safety protocols. All prospective donors will continue to undergo comprehensive health screenings to ensure donation safety.

    The proposed revisions draw support from both global benchmarks and successful regional implementations. The World Health Organization recommends an donor age range of 18-65 years, while several developed nations including the United States, Canada, Australia, and Japan have either adopted similar upper age limits or eliminated them entirely. Chinese provinces such as Hainan and Jiangxi, along with the city of Shenzhen, have already demonstrated the feasibility of these relaxed standards through local regulations.

    Medical evidence presented by the commission indicates that donating 400 milliliters of blood represents less than 10% of total blood volume in adults, causing no harm to healthy individuals. Blood regeneration typically completes within one to two weeks following donation.

    The draft legislation also introduces enhanced protections and incentives for donors, including financial subsidies, additional paid leave, and prioritized access to medical services. Donors would receive exemptions from blood processing costs, while their immediate family members would qualify for either full exemptions or reduced fees. The proposal further mandates establishing at least one fixed donation station in each county-level region, with additional facilities in high-demand areas.

    Despite a national blood donation rate of 11.4 donors per 1,000 people, China continues to experience seasonal, regional, and blood-type-specific shortages exacerbated by an aging population and evolving lifestyles. The commission emphasized that safeguarding donor health and ensuring blood safety remain fundamental principles throughout this modernization effort.

  • HKSAR govt releases first-ever Chinese medicine development blueprint

    HKSAR govt releases first-ever Chinese medicine development blueprint

    HONG KONG – In a landmark move for healthcare development, the Hong Kong Special Administrative Region (HKSAR) government has formally launched its inaugural Chinese Medicine Development Blueprint on December 19, 2024. This comprehensive strategic document represents the region’s first systematic framework for advancing traditional Chinese medicine (TCM) within its healthcare ecosystem.

    The blueprint establishes a multi-phase implementation strategy with clearly defined short-term, medium-term, and long-term objectives across five critical domains: TCM clinical services, professional development, pharmaceutical advancement, cultural preservation, and international expansion. The strategic plan specifically emphasizes enhancing clinical service excellence through clearly defining TCM’s role within Hong Kong’s broader healthcare infrastructure.

    A key component of the initiative involves establishing sophisticated interprofessional collaboration mechanisms that will integrate TCM services more effectively with conventional medical practices. The development plan also addresses pharmaceutical quality control, outlining rigorous standards and management protocols to elevate the overall quality and safety of Chinese medicinal products.

    Health Secretary Lo Chung-mau emphasized the blueprint’s dual purpose during the announcement: “This strategic framework aims to provide Hong Kong residents with higher quality, more comprehensive healthcare services through traditional Chinese medicine, while simultaneously positioning Hong Kong as the premier bridgehead for TCM’s global expansion.”

    The development blueprint emerges as part of Hong Kong’s broader commitment to healthcare innovation and cultural preservation, potentially establishing new international standards for traditional medicine integration within modern healthcare systems.